Cargando…
Use of intraoperative frontal sinus mometasone‐eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps
BACKGROUND: Mometasone‐eluting stents (MES) have demonstrated improvement in short‐term endoscopic outcomes and reduce short‐ to medium‐term rescue interventions. Their effect on the local inflammatory environment, longer‐term patient‐reported outcomes, and radiographic severity have not been studie...
Autores principales: | Schneider, Alexander L., Racette, Samuel D., Kang, Anthony K., Reddy, Abhita T., Huang, Julia H., Lehmann, David S., Price, Caroline P.E., Eide, Jacob G., Rodeghiero, Samuel R., Conley, David B., Welch, Kevin C., Kern, Robert C., Shintani‐Smith, Stephanie, Peters, Anju T., Kato, Atsushi, Stevens, Whitney S., Schleimer, Robert P., Tan, Bruce K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525456/ https://www.ncbi.nlm.nih.gov/pubmed/35362251 http://dx.doi.org/10.1002/alr.23005 |
Ejemplares similares
-
CRS‐PRO and SNOT‐22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis
por: Racette, Samuel D., et al.
Publicado: (2022) -
Anti‐phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polyps
por: Eide, Jacob G., et al.
Publicado: (2022) -
Persistent discharge or edema after endoscopic sinus surgery in patients with chronic rhinosinusitis is associated with a type 1 or 3 endotype
por: Stein, Eli, et al.
Publicado: (2022) -
Mometasone implant for chronic rhinosinusitis
por: Wei, Calvin C, et al.
Publicado: (2012) -
The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps
por: Gevaert, Philippe, et al.
Publicado: (2022)